
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 10, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 10, 2024
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 277, P. 134329 - 134329
Published: Aug. 7, 2024
SARS-CoV-2 induced neuroinflammation contributing to neurological sequelae is one of the critical outcomes long-COVID, however underlying regulatory mechanisms involved therein are poorly understood. We deciphered profile dysregulated microRNAs, their targets, associated pathways, protein-protein interactions (PPI), transcription factor-hub genes interaction networks, hub genes-microRNA co-regulatory networks in Spike-1 (S1) stimulated microglial cells along with candidate drug prediction using RNA-sequencing and multiple bioinformatics approaches. identified 11 microRNAs S1-stimulated (p < 0.05). KEGG analysis revealed involvement important neuroinflammatory pathways such as MAPK signalling, PI3K-AKT Ras signalling axon guidance. PPI further these pathways. Real time PCR validation confirmed a significant upregulation microRNA-30b-5p let-7a-5p; proinflammatory cytokines- IL-6, TNF-α, IL-1β, GM-CSF; inflammatory genes- PIK3CA AKT cells, while PTEN SHIP1 expression was decreased compared non-stimulated cells. Drug indicated resveratrol, diclofenac rapamycin potential drugs based on degree genes. Thus, targeting and/or intermediate molecules would be prospective immunotherapeutic approach alleviating SARS-CoV-2-S1 mediated neuroinflammation; needs investigations.
Language: Английский
Citations
1Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 10, 2024
Language: Английский
Citations
0